[go: up one dir, main page]

Mackie et al., 1991 - Google Patents

The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis

Mackie et al., 1991

Document ID
12731977359815800947
Author
Mackie A
Ferrington C
Cowan S
PALMER K
Publication year
Publication venue
Alimentary pharmacology & therapeutics

External Links

Snippet

Gastric emptying was measured in 9 diabetic patients with autonomic neuropathy (Group 1) and 8 normal controls (Group 2) on 4 occasions after swallowing placebo, 0.5, 1.0 or 2.0 mg of the newly developed prokinetic drug renzapride given double‐blind and in random order …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Nowak et al. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus.
Ricci et al. Effect of metoclopramide in diabetic gastroparesis
McCallum et al. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics.
Mackie et al. The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis
US5945107A (en) Compositions and methods for weight reduction
CN101903033A (en) The purposes of the extract of making by Folium Ginkgo
DE2823174A1 (en) MEDICINAL PRODUCTS FOR THE PROPHYLACTIC TREATMENT OF POSTOPERATIVE DEEP VEIN THROMBOSIS
Kendall et al. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post‐vagotomy–antrectomy gastroparesis
Raptis et al. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man
CN108042755A (en) It is a kind of to be used to treat weakness of the spleen and the stomach oral traditional Chinese medicine composition and its application
Kivistö et al. Enhancement of absorption and effect of glipizide by magnesium hydroxide
CN110664906A (en) Preparation method of health food with blood sugar reducing function
EP0098975B1 (en) Biostimulating drug
KR101888475B1 (en) Compostions for reducing weight using herb medicine
Said et al. A double blinded-randomized clinical study with “Weighlevel”, a combination of four medicinal plants used in traditional Greco-Arab and Islamic medicine
DE60020833T2 (en) MELATONIN FOR THE TREATMENT OF PARALYSIS LEAVED BY BRAIN HIT
Yun et al. Anti-hypertensive effect of Chunghyul-dan (Qingxue-dan) on stroke patients with essential hypertension
CN109999042A (en) Composition and its application comprising dehydrobenzene or its sulfuric ester, levocarnitine, acetyl levocarnitine or their officinal salt
CN109528968A (en) A kind of Chinese medicine composition and its preparation method and application for treating diabetes B
Minocha et al. Erythromycin shortens orocaecal transit time in diabetic male subjects: a double‐blind placebo‐controlled study
Luisto et al. Dantrolene sodium in chronic spasticity of varying etiology: A DOUBLE‐BLIND STUDY
WO2020233459A1 (en) Composition for improving memory and preparation method therefor
Durnin et al. The metabolic effects, and the composition of the tissue lost, in weight reduction by obese patients on treatment with fenfluramine
Stacher et al. Lack of systematic effects of the 5‐hydroxytryptamine 3 receptor antagonist ICS 205‐930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa.
Horowitz et al. Effect of dexfenfluramine on gastric emptying of a mixed solid-liquid meal in obese subjects